Jiamei Chen

Jiamei Chen

Auto-generated profile, based on publicly available information

Jiamei Chen


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJia-Mei Chen
Jia-Mei Chen
AQAi-Ping Qu
Ai-Ping Qu
LWLin-Wei Wang
Lin-Wei Wang
JYJing-Ping Yuan
Jing-Ping Yuan
FYFang Yang
Fang Yang
YLYan Li
Yan Li
Computer-aided image analysis (CAI) can help objectively quantify morphologic features of hematoxylin-eosin (HE) histopathology images and provide potentially useful prognostic information on breast cancer. We performed a CAI workflow on 1,150 HE images from 230 patients with invasive ductal carcinoma (IDC) of the breast. We used a pixel-wise support vector machine classifier for tumor nests (TNs)-stroma segmentation and a marker-controlled watershed algorithm for nuclei segmentation. 730 morphologic parameters were extracted after segmentation and 12 parameters identified by Kaplan-Meier analysis were significantly associated with 8-year disease free survival (P < 0.05 for all). Moreover, four image features including TNs feature (HR 1.327, 95%CI [1.001 - 1.759], P = 0.049), TNs cell nuclei feature (HR 0.729, 95%CI [0.537 - 0.989], P = 0.042), TNs cell density (HR 1.625, 95%CI [1.177 - 2.244], P = 0.003) and stromal cell structure feature (HR 1.596, 95%CI [1.142 - 2.229], P = 0.006) were identified by multivariate Cox proportional hazards model to be new independent prognostic factors. The results indicated that CAI can assist the pathologist in extracting prognostic information from HE histopathology images for IDC. The TNs feature, TNs cell nuclei feature, TNs cell density and stromal cell structure feature could be new prognostic factors.

21 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
JCJia-Mei Chen
Jia-Mei Chen
BLBo Luo
Bo Luo
RMRu Ma
Ru Ma
XLXi-Xi Luo
Xi-Xi Luo
YCYongshun Chen
Yongshun Chen
YLYan Li
Yan Li
Metastasis via lymphatic vessels or blood vessels is the leading cause of death for breast cancer, and lymphangiogenesis and angiogenesis are critical prerequisites for the tumor invasion–metastasis cascade. The research progress for tumor lymphangiogenesis has tended to lag behind that for angiogenesis due to the lack of specific markers. With the discovery of lymphatic endothelial cell (LEC) markers, growing evidence demonstrates that the LEC plays an active role in lymphatic formation and remodeling, tumor cell growth, invasion and intravasation, tumor–microenvironment remodeling, and antitumor immunity. However, some studies have drawn controversial conclusions due to the variation in the LEC markers and lymphangiogenesis assessments used. In this study, we review recent findings on tumor lymphangiogenesis, the most commonly used LEC markers, and parameters for lymphangiogenesis assessments, such as the lymphatic vessel density and lymphatic vessel invasion in human breast cancer. An in-depth understanding of tumor lymphangiogenesis and LEC markers can help to illustrate the mechanisms and distinct roles of lymphangiogenesis in breast cancer progression, which will help in exploring novel potential predictive biomarkers and therapeutic targets for breast cancer.

23 March 2015 in Science China Information Sciences
Verified
Journal Article
Closed access
PDF file
AQAiPing Qu
AiPing Qu
JCJiaMei Chen
JiaMei Chen
LWLinWei Wang
LinWei Wang
JYJingPing Yuan
JingPing Yuan
FYFang Yang
Fang Yang
YLYan Li
Yan Li

3 May 2023 in International Journal of Surgery
Verified
Journal Article
Open access
XFXiangli Fan
Xiangli Fan
WJWang JIng
Wang JIng
YCYongshun Chen
Yongshun Chen
QHQiu Hu
Qiu Hu
YTYuanyuan Tian
Yuanyuan Tian
YCYongshun Chen
Yongshun Chen
Background: The efficacy of endoscopic therapy on the long-term survival outcomes of T1b oesophageal cancer (EC) is unclear, this study was designed to clarify the survival outcomes of endoscopic therapy and to construct a model for predicting the prognosis in T1b EC patients. Methods: This study was performed using the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2017 of patients with T1bN0M0 EC. Cancer-specific survival (CSS) and overall survival (OS) were compared between endoscopic therapy group, esophagectomy group and chemoradiotherapy group, respectively. Stabilized inverse probability treatment weighting was used as the main analysis method. The propensity score matching method and an independent dataset from our hospital were used as sensitivity analysis. The least absolute shrinkage and selection operator regression (Lasso) was employed to sift variables. A prognostic model was then established and was verified in two external validation cohorts. Results: The unadjusted 5-year CSS was 69.5% (95% CI, 61.5–77.5) for endoscopic therapy, 75.0% (95% CI, 71.5–78.5) for esophagectomy and 42.4% (95% CI, 31.0–53.8) for chemoradiotherapy. After stabilized inverse probability treatment weighting adjustment, CSS and OS were similar in endoscopic therapy and esophagectomy groups (P=0.32, P=0.83), while the CSS and OS of chemoradiotherapy patients were inferior to endoscopic therapy patients (P<0.01, P<0.01). Age, histology, grade, tumour size, and treatment were selected to build the prediction model. The area under the curve of receiver operating characteristics of 1, 3, and 5 years in the validation cohort 1 were 0.631, 0.618, 0.638, and 0.733, 0.683, 0.768 in the validation cohort 2. The calibration plots also demonstrated the consistency of predicted and actual values in the two external validation cohorts. Conclusion: Endoscopic therapy achieved comparable long-term survival outcomes to esophagectomy for T1b EC patients. The prediction model developed performed well in calculating the OS of patients with T1b EC.

5 December 2022 in Human Pathology
Verified
Journal Article
Open access
JCJiamei Chen
Jiamei Chen
YYYang Yang
Yang Yang
BLBo Luo
Bo Luo
YWYaofeng Wen
Yaofeng Wen
QCQingzhong Chen
Qingzhong Chen
Dahong QianDahong Qian
Dahong Qian
Lymphovascular invasion, specifically lymph-blood vessel invasion (LBVI), is a risk factor for metastases in breast invasive ductal carcinoma (IDC) and is routinely screened using hematoxylin-eosin histopathological images. However, routine reports only describe whether LBVI is present and does not provide other potential prognostic information of LBVI. This study aims to evaluate the clinical significance of LBVI in 685 IDC cases and explore the added predictive value of LBVI on lymph node metastases (LNM) via supervised deep learning (DL), an expert-experience embedded knowledge transfer learning (EEKT) model in 40 LBVI-positive cases signed by the routine report. Multivariate logistic regression and propensity score matching analysis demonstrated that LBVI (OR 4.203, 95% CI 2.809-6.290, P < 0.001) was a significant risk factor for LNM. Then, the EEKT model trained on 5780 image patches automatically segmented LBVI with a patch-wise Dice similarity coefficient of 0.930 in the test set and output counts, location, and morphometric features of the LBVIs. Some morphometric features were beneficial for further stratification within the 40 LBVI-positive cases. The results showed that LBVI in cases with LNM had a higher short-to-long side ratio of the minimum rectangle (MR) (0.686 vs. 0.480, P = 0.001), LBVI-to-MR area ratio (0.774 vs. 0.702, P = 0.002), and solidity (0.983 vs. 0.934, P = 0.029) compared to LBVI in cases without LNM. The results highlight the potential of DL to assist pathologists in quantifying LBVI and, more importantly, in exploring added prognostic information from LBVI.

1 November 2014
Verified
Conference Paper
Closed access
AQAiping Qu
Aiping Qu
JCJiamei Chen
Jiamei Chen
LWLinwei Wang
Linwei Wang
JYJingping Yuan
Jingping Yuan
FYFang Yang
Fang Yang
YLYan Li
Yan Li
Accurately predicting the risk of cancer recurrence and metastasis is critical to cancer individualized treatment. Currently, physicians commonly use histological grade, which is determined by pathologists via performing a semi-quantitative analysis of three histological and cytological features on Hematoxylin-Eosin (HE) stained histopathological images, to assess the prognosis of a breast cancer patient and the treatment option. In order to efficiently and objectively make full use of the underlying invaluable information in HE stained histopathological images, this work proposes a computational method to extract the potential morphological information as features to establish an classification model for the prognosis of cancer. Firstly, we propose a method based on the pixel-wise support vector machine (SVM) classifier for segmenting tumor nests-stroma and a method based on the marker-controlled watershed for segmenting cell nucleus, then we subclassify all image objects and extract a rich set of predefined quantitative morphological features. Secondly, a classification model based on these measurements is used to predict the binary patients' outcome of 8-year disease free survival (8-DFS). Finally, the predict model is tested on two independent cohorts of breast cancer patients. Experimental results demonstrate the efficiency and effectiveness of the proposed method, providing valuable and reasonable prognosis information for breast cancer.